Professional services to produce clinical grade tarp (TCR??alternative reading frame protein) peptides under cgmp conditions that shall cover the entire 58 amino acid sequence of the tarp protein as…
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201600441P
- Awardee
-
Polypeptide Laboratories San Diego, LLC UEI KULKXN9J6PF9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $190,500
Award facts
- Opportunity
-
- N02CO6260357 Solicitation number
- Production of cGMP TARP Peptides Award Notice · Posted Jun 10, 2016
- Contract value 100% obligated
- $190,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $190,500.00, was issued by the National Cancer Institute (NCI) to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for the production of clinical-grade TARP (T-cell receptor-alternative reading frame protein) peptides under Current Good Manufacturing Practice (CGMP) conditions. The contract covers the entire 58 amino acid sequence of the TARP protein, as well as the two original 9 amino acid TARP 27-35 and 29-37-9V proteins.
Polypeptide Labs is a specialized manufacturer and service provider in the biotechnology and pharmaceutical research sector, registered in the System for Award Management (SAM.gov) since 2003. The company has a history of providing critical support to various federal agencies, particularly within the National Institutes of Health (NIH), by delivering specialized pharmaceutical and research compounds essential for advanced biomedical investigations. This contract award is not associated with a set-aside designation, indicating Polypeptide Labs' competitive capabilities in meeting federal research requirements.
In addition to this contract, Polypeptide Labs currently holds two significant Indefinite Delivery Contracts (IDVs) with NIH agencies: a $49,713,679 single-award IDV with the National Center for Advancing Translational Sciences (NCATS) for chemistry, manufacturing, and controls (CMC) services, and a $2,781,317 IDV with the National Institute on Drug Abuse (NIDA) for the synthesis and distribution of opioid and related peptides. These IDVs demonstrate the company's specialized expertise in providing high-quality peptide-related services across multiple research domains, supporting critical biomedical research initiatives through comprehensive contract development and manufacturing services.
Description
Professional services to produce clinical grade tarp (TCR??alternative reading frame protein) peptides under cgmp conditions that shall cover the entire 58 amino acid sequence of the tarp protein as well as include the original two 9 amino acid proteins tarp 27-35 and 29-37-9V
Quick answers
Who was awarded contract HHSN261201600441P?
HHSN261201600441P was awarded to Polypeptide Laboratories San Diego, LLC by National Cancer Institute (National Institutes of Health) on July 1, 2016.
How much is contract HHSN261201600441P worth?
The government has obligated $190,500 on HHSN261201600441P.
Was contract HHSN261201600441P competed?
The extent of competition for HHSN261201600441P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award